Scarsdale, NY, United States of America

Kun Lu

USPTO Granted Patents = 1 

Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2023

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Kun Lu: Innovator in Antibody Development

Introduction

Kun Lu is a prominent inventor based in Scarsdale, NY (US). He has made significant contributions to the field of antibody development, showcasing his expertise through innovative methodologies.

Latest Patents

Kun Lu holds a patent titled "Ce-western applications for antibody development." This patent describes methods for detecting and/or discriminating between variants of an antibody contaminating protein or multiple antibodies in a sample by a physical parameter. The method includes separating protein components of a sample by molecular weight or charge in one or more capillaries using capillary electrophoresis. It also involves immobilizing the protein components of the sample within the capillaries and contacting them with one or more primary antibodies that specifically bind to the antibody, the contaminating protein, or multiple antibodies in the sample. This innovative approach enhances the detection and discrimination of variants in complex samples.

Career Highlights

Kun Lu is currently employed at Regeneron Pharmaceuticals, Inc., where he continues to advance research in antibody development. His work is characterized by a commitment to improving methodologies that can lead to better diagnostic and therapeutic solutions.

Collaborations

Some of his notable coworkers include Nisha Palackal and Gangadhar Dhulipala, who contribute to the collaborative environment at Regeneron Pharmaceuticals, Inc.

Conclusion

Kun Lu's innovative work in antibody development exemplifies the impact of dedicated research in the field of biotechnology. His contributions are paving the way for advancements in medical diagnostics and therapeutics.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…